EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis



Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. European Working Group on Clinical Cell Analysis



Cytometry 34(3): 128-142



The need for a rapid and reliable marker for the engraftment potential of hematopoietic stem and progenitor cell (HPC) transplants has led to the development of flow cytometric assays to quantitate such cells on the basis of their expression of CD34. The variability associated with enumeration of low-frequency cells (i.e., as low as 0.1% or 5 cells/microl) is exceedingly large, but recent developments have improved the accuracy and precision of the assay. Here, we review and compare the major techniques. Based on the current state of the art, we recommend 1) bright fluorochrome conjugates of class II or III monoclonal antibodies (mAbs) that detect all glycoforms of CD34, 2) use of a vital nucleic acid dye to exclude platelets, unlysed red cells, and debris or use of 7-amino actinomycin D to exclude dead cells during data acquisition, 3) counterstaining with CD45 mAb to be included in the definition of HPC, 4) during list mode data analysis, Boolean gating to resolve the CD34+ HPCs from irrelevant cell populations on the basis of the low levels of CD45 expression and low sideward light-scatter signals of HPCs, 5) inclusion of CD34dim and CD34bright populations in the CD34+ cell count, 6) omission of the negative control staining, and 7) for apheresis products, enumeration of at least 100 CD34+ cells to ensure a 10% precision. Unresolved technical questions are 1) the replacement of conventional dual-platform by single-platform assay formats, i.e., derivation of absolute CD34+ cell counts from a single flow cytometric assessment instead of from combined flow cytometer (percent CD34+) and hematology analyzer (absolute leukocyte count) data, 2) the cross-calibration of the available single-platform assays, and 3) the optimal method for sample preparation. An important clinical question to be addressed is the definition of the precise phenotypes and required numbers of HPCs responsible for short- and long-term recovery to optimize HPC transplant strategies.

(PDF emailed within 1 workday: $29.90)

Accession: 046103770

Download citation: RISBibTeXText

PMID: 9696157



Related references

Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells. Cytometry. 34(3): 128-142, E 15, 1998

Flow cytometric enumeration of CD34+ hematopoietic stem and progenitor cells in leukapheresis product and bone marrow for clinical transplantation: a comparison of three methods. Folia Histochemica et Cytobiologica 44(1): 53-60, 2006

The new Sysmex XN-2000 automated blood cell analyzer more accurately measures the absolute number and the proportion of hematopoietic stem and progenitor cells than XE-2100 when compared to flow cytometric enumeration of CD34+ cells. Annals of Laboratory Medicine 35(1): 146-148, 2016

Flow cytometric enumeration and immunophenotyping of hematopoietic stem and progenitor cells. Journal of Biological Regulators & Homeostatic Agents 15(1): 14-22, January-March, 2001

North American Multicenter Study on flow cytometric enumeration of CD34+ hematopoietic stem cells. Journal of HematoTherapy 5(3): 227-236, 1996

Semi-automated flow cytometric analysis of CD34-expressing hematopoietic cells in peripheral blood progenitor cell apheresis products. Transfusion (Bethesda) 39(11-12): 1220-1226, 1999

Use of flow cytometric CD34 analysis to quantify hematopoietic progenitor cells. Leukemia & Lymphoma 10(6): 443-451, 1993

The diversity of human hematopoietic stem/progenitor cells. I. Two-color flow cytometric analysis of the different functional subpopulations of CD 34+ hematopoietic stem/progenitor cells riched from human bone marrow. Shi Yan Sheng Wu Xue Bao 29(1): 49-57, 1996

Flow cytometric analysis of hemetopoietic progenitor cells in peripheral blood stem cell harvest from patients with CD34 positive acute leukemia. Journal of Immunological Methods 247(1-2): 9-15, 1 January, 2001

Automated analysis of flow cytometric data for CD34+ stem cell enumeration using a probability state model. Cytometry. Part B, Clinical Cytometry 82(5): 313-318, 2013

Enumeration of CD34+ hematopoietic stem and progenitor cells. Current Protocols in Cytometry Chapter 6: Unit 6.4-Unit 6.4, 2008

Flow cytometric quantitation of immunofluorescence intensity: problems and perspectives. European Working Group on Clinical Cell Analysis. Cytometry 33(2): 166-178, 1998

European Working Group on Clinical Cell Analysis: Consensus protocol for the flow cytometric characterisation of platelet function. Thrombosis and Haemostasis 79(5): 885-896, 1998

Monoclonal antibodies with neuroblastoma specificity: a flow cytometric analysis of cross-reactivity with CD34+ hematopoietic stem cells. Journal of HematoTherapy & Stem Cell Research 9(6): 867-875, 2001

Thy-1 and c-kit receptor expression on CD34+ hematopoietic progenitor cells A five dimensional flow cytometric study. Haematologica 83(7): 587-592, July, 1998